APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bidirectional Immunomodulator

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Bidirectional Immunomodulator Industry Growth and Trends Forecast to 2032

28 December 2025108 pages

Choose your research edition.

Industry ResearchBidirectional Immunomodulator Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Bidirectional Immunomodulator Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Bidirectional Immunomodulator Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bidirectional Immunomodulator Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Bidirectional Immunomodulator Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Bidirectional Immunomodulator market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Bidirectional Immunomodulator is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Bidirectional Immunomodulator is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bidirectional Immunomodulator is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Bidirectional Immunomodulator include Amgen, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Gilead Sciences, GSK, Regeneron Pharmaceuticals, AbbVie and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Bidirectional Immunomodulator market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Bidirectional Immunomodulator market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Bidirectional Immunomodulator market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Bidirectional Immunomodulator.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Bidirectional Immunomodulator market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Bidirectional Immunomodulator Market by Company

Amgen

AstraZeneca

Boehringer Ingelheim

Bristol Myers Squibb

Gilead Sciences

GSK

Regeneron Pharmaceuticals

AbbVie

Pfizer

Roche

Merck

Novartis

Takeda Pharmaceuticals

Zhifei Biological

Bidirectional Immunomodulator Segment by Type

Dexamethasone

Rapamycin

Bortezomib

Thalidamide and Its Derivatives

Other

Bidirectional Immunomodulator Segment by Application

Cancer

Autoimmune Diseases

Other

Bidirectional Immunomodulator Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bidirectional Immunomodulator market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bidirectional Immunomodulator and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bidirectional Immunomodulator.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Bidirectional Immunomodulator manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Bidirectional Immunomodulator in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Dexamethasone Table 2. Major Company of Rapamycin Table 3. Major Company of Bortezomib Table 4. Major Company of Thalidamide and Its Derivatives Table 5. Major Company of Other Table 6. Global Bidirectional Immunomodulator Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Bidirectional Immunomodulator Sales by Type (2021-2026) & (K Units) Table 8. Global Bidirectional Immunomodulator Sales Market Share in Volume by Type (2021-2026) Table 9. Global Bidirectional Immunomodulator Sales by Type (2021-2026) & (US$ Million) Table 10. Global Bidirectional Immunomodulator Sales Market Share in Value by Type (2021-2026) Table 11. Global Bidirectional Immunomodulator Price by Type (2021-2026) & (US$/Unit) Table 12. Global Bidirectional Immunomodulator Sales by Type (2027-2032) & (K Units) Table 13. Global Bidirectional Immunomodulator Sales Market Share in Volume by Type (2027-2032) Table 14. Global Bidirectional Immunomodulator Sales by Type (2027-2032) & (US$ Million) Table 15. Global Bidirectional Immunomodulator Sales Market Share in Value by Type (2027-2032) Table 16. Global Bidirectional Immunomodulator Price by Type (2027-2032) & (US$/Unit) Table 17. North America Bidirectional Immunomodulator Sales by Type (2021-2026) & (K Units) Table 18. North America Bidirectional Immunomodulator Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Bidirectional Immunomodulator Sales by Type (2021-2026) & (K Units) Table 20. Europe Bidirectional Immunomodulator Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Bidirectional Immunomodulator Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Bidirectional Immunomodulator Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Bidirectional Immunomodulator Sales by Type (2021-2026) & (K Units) Table 24. Latin America Bidirectional Immunomodulator Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Bidirectional Immunomodulator Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Bidirectional Immunomodulator Sales by Type (2021-2026) & (US$ Million) Table 27. Bidirectional Immunomodulator Industry Trends Table 28. Bidirectional Immunomodulator Industry Drivers Table 29. Bidirectional Immunomodulator Industry Opportunities and Challenges Table 30. Bidirectional Immunomodulator Industry Restraints Table 31. Global Bidirectional Immunomodulator Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Bidirectional Immunomodulator Revenue Market Share by Company (2021-2026) Table 33. Global Bidirectional Immunomodulator Sales by Company (2021-2026) & (K Units) Table 34. Global Bidirectional Immunomodulator Sales Share by Company (2021-2026) Table 35. Global Bidirectional Immunomodulator Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Bidirectional Immunomodulator Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Bidirectional Immunomodulator Major Company Production Sites and Headquarters Table 38. Global Bidirectional Immunomodulator Company, Product Type & Application Table 39. Global Bidirectional Immunomodulator Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Bidirectional Immunomodulator by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Bidirectional Immunomodulator Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Bidirectional Immunomodulator Sales by Region (2021-2026) & (K Units) Table 44. Global Bidirectional Immunomodulator Sales Market Share in Volume by Region (2021-2026) Table 45. Global Bidirectional Immunomodulator Sales by Region (2021-2026) & (US$ Million) Table 46. Global Bidirectional Immunomodulator Sales Market Share in Value by Region (2021-2026) Table 47. Global Bidirectional Immunomodulator Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Bidirectional Immunomodulator Sales by Region (2027-2032) & (K Units) Table 49. Global Bidirectional Immunomodulator Sales Market Share in Volume by Region (2027-2032) Table 50. Global Bidirectional Immunomodulator Sales by Region (2027-2032) & (US$ Million) Table 51. Global Bidirectional Immunomodulator Sales Market Share in Value by Region (2027-2032) Table 52. Global Bidirectional Immunomodulator Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Bidirectional Immunomodulator Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Bidirectional Immunomodulator Sales by Application (2021-2026) & (K Units) Table 55. Global Bidirectional Immunomodulator Sales Market Share in Volume by Application (2021-2026) Table 56. Global Bidirectional Immunomodulator Sales by Application (2021-2026) & (US$ Million) Table 57. Global Bidirectional Immunomodulator Sales Market Share in Value by Application (2021-2026) Table 58. Global Bidirectional Immunomodulator Price by Application (2021-2026) & (US$/Unit) Table 59. Global Bidirectional Immunomodulator Sales by Application (2027-2032) & (K Units) Table 60. Global Bidirectional Immunomodulator Sales Market Share in Volume by Application (2027-2032) Table 61. Global Bidirectional Immunomodulator Sales by Application (2027-2032) & (US$ Million) Table 62. Global Bidirectional Immunomodulator Sales Market Share in Value by Application (2027-2032) Table 63. Global Bidirectional Immunomodulator Price by Application (2027-2032) & (US$/Unit) Table 64. North America Bidirectional Immunomodulator Sales by Application (2021-2026) & (K Units) Table 65. North America Bidirectional Immunomodulator Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Bidirectional Immunomodulator Sales by Application (2021-2026) & (K Units) Table 67. Europe Bidirectional Immunomodulator Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Bidirectional Immunomodulator Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Bidirectional Immunomodulator Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Bidirectional Immunomodulator Sales by Application (2021-2026) & (K Units) Table 71. Latin America Bidirectional Immunomodulator Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Bidirectional Immunomodulator Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Bidirectional Immunomodulator Sales by Application (2021-2026) & (US$ Million) Table 74. Amgen Company Information Table 75. Amgen Business Overview Table 76. Amgen Bidirectional Immunomodulator Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Amgen Bidirectional Immunomodulator Product Portfolio Table 78. Amgen Recent Development Table 79. AstraZeneca Company Information Table 80. AstraZeneca Business Overview Table 81. AstraZeneca Bidirectional Immunomodulator Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. AstraZeneca Bidirectional Immunomodulator Product Portfolio Table 83. AstraZeneca Recent Development Table 84. Boehringer Ingelheim Company Information Table 85. Boehringer Ingelheim Business Overview Table 86. Boehringer Ingelheim Bidirectional Immunomodulator Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Boehringer Ingelheim Bidirectional Immunomodulator Product Portfolio Table 88. Boehringer Ingelheim Recent Development Table 89. Bristol Myers Squibb Company Information Table 90. Bristol Myers Squibb Business Overview Table 91. Bristol Myers Squibb Bidirectional Immunomodulator Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Bristol Myers Squibb Bidirectional Immunomodulator Product Portfolio Table 93. Bristol Myers Squibb Recent Development Table 94. Gilead Sciences Company Information Table 95. Gilead Sciences Business Overview Table 96. Gilead Sciences Bidirectional Immunomodulator Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Gilead Sciences Bidirectional Immunomodulator Product Portfolio Table 98. Gilead Sciences Recent Development Table 99. GSK Company Information Table 100. GSK Business Overview Table 101. GSK Bidirectional Immunomodulator Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. GSK Bidirectional Immunomodulator Product Portfolio Table 103. GSK Recent Development Table 104. Regeneron Pharmaceuticals Company Information Table 105. Regeneron Pharmaceuticals Business Overview Table 106. Regeneron Pharmaceuticals Bidirectional Immunomodulator Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Regeneron Pharmaceuticals Bidirectional Immunomodulator Product Portfolio Table 108. Regeneron Pharmaceuticals Recent Development Table 109. AbbVie Company Information Table 110. AbbVie Business Overview Table 111. AbbVie Bidirectional Immunomodulator Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. AbbVie Bidirectional Immunomodulator Product Portfolio Table 113. AbbVie Recent Development Table 114. Pfizer Company Information Table 115. Pfizer Business Overview Table 116. Pfizer Bidirectional Immunomodulator Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Pfizer Bidirectional Immunomodulator Product Portfolio Table 118. Pfizer Recent Development Table 119. Roche Company Information Table 120. Roche Business Overview Table 121. Roche Bidirectional Immunomodulator Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Roche Bidirectional Immunomodulator Product Portfolio Table 123. Roche Recent Development Table 124. Merck Company Information Table 125. Merck Business Overview Table 126. Merck Bidirectional Immunomodulator Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Merck Bidirectional Immunomodulator Product Portfolio Table 128. Merck Recent Development Table 129. Novartis Company Information Table 130. Novartis Business Overview Table 131. Novartis Bidirectional Immunomodulator Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Novartis Bidirectional Immunomodulator Product Portfolio Table 133. Novartis Recent Development Table 134. Takeda Pharmaceuticals Company Information Table 135. Takeda Pharmaceuticals Business Overview Table 136. Takeda Pharmaceuticals Bidirectional Immunomodulator Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Takeda Pharmaceuticals Bidirectional Immunomodulator Product Portfolio Table 138. Takeda Pharmaceuticals Recent Development Table 139. Zhifei Biological Company Information Table 140. Zhifei Biological Business Overview Table 141. Zhifei Biological Bidirectional Immunomodulator Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Zhifei Biological Bidirectional Immunomodulator Product Portfolio Table 143. Zhifei Biological Recent Development Table 144. North America Bidirectional Immunomodulator Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 145. North America Bidirectional Immunomodulator Sales by Country (2021-2026) & (K Units) Table 146. North America Bidirectional Immunomodulator Sales Market Share by Country (2021-2026) Table 147. North America Bidirectional Immunomodulator Sales Forecast by Country (2027-2032) & (K Units) Table 148. North America Bidirectional Immunomodulator Sales Market Share Forecast by Country (2027-2032) Table 149. North America Bidirectional Immunomodulator Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. North America Bidirectional Immunomodulator Market Size by Country (2021-2026) & (US$ Million) Table 151. North America Bidirectional Immunomodulator Market Share by Country (2021-2026) Table 152. North America Bidirectional Immunomodulator Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. North America Bidirectional Immunomodulator Market Share Forecast by Country (2027-2032) Table 154. Europe Bidirectional Immunomodulator Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 155. Europe Bidirectional Immunomodulator Sales by Country (2021-2026) & (K Units) Table 156. Europe Bidirectional Immunomodulator Sales Market Share by Country (2021-2026) Table 157. Europe Bidirectional Immunomodulator Sales Forecast by Country (2027-2032) & (K Units) Table 158. Europe Bidirectional Immunomodulator Sales Market Share Forecast by Country (2027-2032) Table 159. Europe Bidirectional Immunomodulator Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. Europe Bidirectional Immunomodulator Market Size by Country (2021-2026) & (US$ Million) Table 161. Europe Bidirectional Immunomodulator Market Share by Country (2021-2026) Table 162. Europe Bidirectional Immunomodulator Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. Europe Bidirectional Immunomodulator Market Share Forecast by Country (2027-2032) Table 164. Asia-Pacific Bidirectional Immunomodulator Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 165. Asia-Pacific Bidirectional Immunomodulator Sales by Country (2021-2026) & (K Units) Table 166. Asia-Pacific Bidirectional Immunomodulator Sales Market Share by Country (2021-2026) Table 167. Asia-Pacific Bidirectional Immunomodulator Sales Forecast by Country (2027-2032) & (K Units) Table 168. Asia-Pacific Bidirectional Immunomodulator Sales Market Share Forecast by Country (2027-2032) Table 169. Asia-Pacific Bidirectional Immunomodulator Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 170. Asia-Pacific Bidirectional Immunomodulator Market Size by Country (2021-2026) & (US$ Million) Table 171. Asia-Pacific Bidirectional Immunomodulator Market Share by Country (2021-2026) Table 172. Asia-Pacific Bidirectional Immunomodulator Market Size Forecast by Country (2027-2032) & (US$ Million) Table 173. Asia-Pacific Bidirectional Immunomodulator Market Share Forecast by Country (2027-2032) Table 174. Latin America Bidirectional Immunomodulator Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 175. Latin America Bidirectional Immunomodulator Sales by Country (2021-2026) & (K Units) Table 176. Latin America Bidirectional Immunomodulator Sales Market Share by Country (2021-2026) Table 177. Latin America Bidirectional Immunomodulator Sales Forecast by Country (2027-2032) & (K Units) Table 178. Latin America Bidirectional Immunomodulator Sales Market Share Forecast by Country (2027-2032) Table 179. Latin America Bidirectional Immunomodulator Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 180. Latin America Bidirectional Immunomodulator Market Size by Country (2021-2026) & (US$ Million) Table 181. Latin America Bidirectional Immunomodulator Market Share by Country (2021-2026) Table 182. Latin America Bidirectional Immunomodulator Market Size Forecast by Country (2027-2032) & (US$ Million) Table 183. Latin America Bidirectional Immunomodulator Market Share Forecast by Country (2027-2032) Table 184. Middle East and Africa Bidirectional Immunomodulator Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 185. Middle East and Africa Bidirectional Immunomodulator Sales by Country (2021-2026) & (K Units) Table 186. Middle East and Africa Bidirectional Immunomodulator Sales Market Share by Country (2021-2026) Table 187. Middle East and Africa Bidirectional Immunomodulator Sales Forecast by Country (2027-2032) & (K Units) Table 188. Middle East and Africa Bidirectional Immunomodulator Sales Market Share Forecast by Country (2027-2032) Table 189. Middle East and Africa Bidirectional Immunomodulator Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 190. Middle East and Africa Bidirectional Immunomodulator Market Size by Country (2021-2026) & (US$ Million) Table 191. Middle East and Africa Bidirectional Immunomodulator Market Share by Country (2021-2026) Table 192. Middle East and Africa Bidirectional Immunomodulator Market Size Forecast by Country (2027-2032) & (US$ Million) Table 193. Middle East and Africa Bidirectional Immunomodulator Market Share Forecast by Country (2027-2032) Table 194. Key Raw Materials Table 195. Raw Materials Key Suppliers Table 196. Bidirectional Immunomodulator Distributors List Table 197. Bidirectional Immunomodulator Customers List Table 198. Research Programs/Design for This Report Table 199. Authors List of This Report Table 200. Secondary Sources Table 201. Primary Sources List of Figures Figure 1. Bidirectional Immunomodulator Image Figure 2. Global Bidirectional Immunomodulator Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bidirectional Immunomodulator Market Size (2021-2032) & (US$ Million) Figure 4. Global Bidirectional Immunomodulator Sales (2021-2032) & (K Units) Figure 5. Dexamethasone Image Figure 6. Global Dexamethasone Sales YoY Growth (2021-2032) & (K Units) Figure 7. Rapamycin Image Figure 8. Global Rapamycin Sales YoY Growth (2021-2032) & (K Units) Figure 9. Bortezomib Image Figure 10. Global Bortezomib Sales YoY Growth (2021-2032) & (K Units) Figure 11. Thalidamide and Its Derivatives Image Figure 12. Global Thalidamide and Its Derivatives Sales YoY Growth (2021-2032) & (K Units) Figure 13. Other Image Figure 14. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Bidirectional Immunomodulator Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Bidirectional Immunomodulator Market Share by Type 2025 VS 2032 Figure 17. North America Bidirectional Immunomodulator Sales Market Share in Volume by Type in 2025 Figure 18. North America Bidirectional Immunomodulator Sales Market Share in Value by Type in 2025 Figure 19. Europe Bidirectional Immunomodulator Sales Market Share in Volume by Type in 2025 Figure 20. Europe Bidirectional Immunomodulator Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Bidirectional Immunomodulator Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Bidirectional Immunomodulator Sales Market Share in Value by Type in 2025 Figure 23. Latin America Bidirectional Immunomodulator Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Bidirectional Immunomodulator Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Bidirectional Immunomodulator Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Bidirectional Immunomodulator Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Bidirectional Immunomodulator Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Cancer Image Figure 30. Global Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 31. Autoimmune Diseases Image Figure 32. Global Autoimmune Diseases Sales YoY Growth (2021-2032) & (K Units) Figure 33. Other Image Figure 34. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Bidirectional Immunomodulator Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Bidirectional Immunomodulator Market Share by Application 2025 VS 2032 Figure 37. North America Bidirectional Immunomodulator Sales Market Share in Volume by Application in 2025 Figure 38. North America Bidirectional Immunomodulator Sales Market Share in Value by Application in 2025 Figure 39. Europe Bidirectional Immunomodulator Sales Market Share in Volume by Application in 2025 Figure 40. Europe Bidirectional Immunomodulator Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Bidirectional Immunomodulator Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Bidirectional Immunomodulator Sales Market Share in Value by Application in 2025 Figure 43. Latin America Bidirectional Immunomodulator Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Bidirectional Immunomodulator Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Bidirectional Immunomodulator Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Bidirectional Immunomodulator Sales Market Share in Value by Application in 2025 Figure 47. North America Bidirectional Immunomodulator Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Bidirectional Immunomodulator Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Bidirectional Immunomodulator Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Bidirectional Immunomodulator Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Bidirectional Immunomodulator Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Bidirectional Immunomodulator Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Bidirectional Immunomodulator Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Bidirectional Immunomodulator Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Bidirectional Immunomodulator Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Bidirectional Immunomodulator Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Bidirectional Immunomodulator Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Bidirectional Immunomodulator Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Bidirectional Immunomodulator Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Bidirectional Immunomodulator Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Bidirectional Immunomodulator Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Bidirectional Immunomodulator Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Bidirectional Immunomodulator Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Bidirectional Immunomodulator Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Bidirectional Immunomodulator Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Bidirectional Immunomodulator Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Bidirectional Immunomodulator Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Bidirectional Immunomodulator Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Dexamethasone
  • Rapamycin
  • Bortezomib
  • Thalidamide and Its Derivatives
  • Other
Applications
  • Cancer
  • Autoimmune Diseases
  • Other
Companies covered
  • Amgen
  • AstraZeneca
  • Boehringer Ingelheim
  • Bristol Myers Squibb
  • Gilead Sciences
  • GSK
  • Regeneron Pharmaceuticals
  • AbbVie
  • Pfizer
  • Roche
  • Merck
  • Novartis
  • Takeda Pharmaceuticals
  • Zhifei Biological

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Bidirectional Immunomodulator Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Bidirectional Immunomodulator Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Bidirectional Immunomodulator Market by Type
  6. 1.3.1 Dexamethasone
  7. 1.3.2 Rapamycin
  8. 1.3.3 Bortezomib
  9. 1.3.4 Thalidamide and Its Derivatives
  10. 1.3.5 Other
  11. 1.4 Global Bidirectional Immunomodulator Market Size by Type
  12. 1.4.1 Global Bidirectional Immunomodulator Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Bidirectional Immunomodulator Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Bidirectional Immunomodulator Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Bidirectional Immunomodulator Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Bidirectional Immunomodulator Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Bidirectional Immunomodulator Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Bidirectional Immunomodulator Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Bidirectional Immunomodulator Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Bidirectional Immunomodulator Industry Trends
  2. 2.2 Bidirectional Immunomodulator Industry Drivers
  3. 2.3 Bidirectional Immunomodulator Industry Opportunities and Challenges
  4. 2.4 Bidirectional Immunomodulator Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Bidirectional Immunomodulator Revenue (2021-2026)
  2. 3.2 Global Top Players by Bidirectional Immunomodulator Sales (2021-2026)
  3. 3.3 Global Top Players by Bidirectional Immunomodulator Price (2021-2026)
  4. 3.4 Global Bidirectional Immunomodulator Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Bidirectional Immunomodulator Major Company Production Sites & Headquarters
  6. 3.6 Global Bidirectional Immunomodulator Company, Product Type & Application
  7. 3.7 Global Bidirectional Immunomodulator Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Bidirectional Immunomodulator Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Bidirectional Immunomodulator Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Bidirectional Immunomodulator Tier 1, Tier 2, and Tier 3
4 Bidirectional Immunomodulator Regional Status and Outlook
  1. 4.1 Global Bidirectional Immunomodulator Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Bidirectional Immunomodulator Historic Market Size by Region
  3. 4.2.1 Global Bidirectional Immunomodulator Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Bidirectional Immunomodulator Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Bidirectional Immunomodulator Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Bidirectional Immunomodulator Forecasted Market Size by Region
  7. 4.3.1 Global Bidirectional Immunomodulator Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Bidirectional Immunomodulator Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Bidirectional Immunomodulator Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Bidirectional Immunomodulator by Application
  1. 5.1 Bidirectional Immunomodulator Market by Application
  2. 5.1.1 Cancer
  3. 5.1.2 Autoimmune Diseases
  4. 5.1.3 Other
  5. 5.2 Global Bidirectional Immunomodulator Market Size by Application
  6. 5.2.1 Global Bidirectional Immunomodulator Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Bidirectional Immunomodulator Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Bidirectional Immunomodulator Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Bidirectional Immunomodulator Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Bidirectional Immunomodulator Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Bidirectional Immunomodulator Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Bidirectional Immunomodulator Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Bidirectional Immunomodulator Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Amgen
  2. 6.1.1 Amgen Company Information
  3. 6.1.2 Amgen Business Overview
  4. 6.1.3 Amgen Bidirectional Immunomodulator Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Amgen Bidirectional Immunomodulator Product Portfolio
  6. 6.1.5 Amgen Recent Developments
  7. 6.2 AstraZeneca
  8. 6.2.1 AstraZeneca Company Information
  9. 6.2.2 AstraZeneca Business Overview
  10. 6.2.3 AstraZeneca Bidirectional Immunomodulator Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 AstraZeneca Bidirectional Immunomodulator Product Portfolio
  12. 6.2.5 AstraZeneca Recent Developments
  13. 6.3 Boehringer Ingelheim
  14. 6.3.1 Boehringer Ingelheim Company Information
  15. 6.3.2 Boehringer Ingelheim Business Overview
  16. 6.3.3 Boehringer Ingelheim Bidirectional Immunomodulator Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Boehringer Ingelheim Bidirectional Immunomodulator Product Portfolio
  18. 6.3.5 Boehringer Ingelheim Recent Developments
  19. 6.4 Bristol Myers Squibb
  20. 6.4.1 Bristol Myers Squibb Company Information
  21. 6.4.2 Bristol Myers Squibb Business Overview
  22. 6.4.3 Bristol Myers Squibb Bidirectional Immunomodulator Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bristol Myers Squibb Bidirectional Immunomodulator Product Portfolio
  24. 6.4.5 Bristol Myers Squibb Recent Developments
  25. 6.5 Gilead Sciences
  26. 6.5.1 Gilead Sciences Company Information
  27. 6.5.2 Gilead Sciences Business Overview
  28. 6.5.3 Gilead Sciences Bidirectional Immunomodulator Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Gilead Sciences Bidirectional Immunomodulator Product Portfolio
  30. 6.5.5 Gilead Sciences Recent Developments
  31. 6.6 GSK
  32. 6.6.1 GSK Company Information
  33. 6.6.2 GSK Business Overview
  34. 6.6.3 GSK Bidirectional Immunomodulator Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 GSK Bidirectional Immunomodulator Product Portfolio
  36. 6.6.5 GSK Recent Developments
  37. 6.7 Regeneron Pharmaceuticals
  38. 6.7.1 Regeneron Pharmaceuticals Company Information
  39. 6.7.2 Regeneron Pharmaceuticals Business Overview
  40. 6.7.3 Regeneron Pharmaceuticals Bidirectional Immunomodulator Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Regeneron Pharmaceuticals Bidirectional Immunomodulator Product Portfolio
  42. 6.7.5 Regeneron Pharmaceuticals Recent Developments
  43. 6.8 AbbVie
  44. 6.8.1 AbbVie Company Information
  45. 6.8.2 AbbVie Business Overview
  46. 6.8.3 AbbVie Bidirectional Immunomodulator Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 AbbVie Bidirectional Immunomodulator Product Portfolio
  48. 6.8.5 AbbVie Recent Developments
  49. 6.9 Pfizer
  50. 6.9.1 Pfizer Company Information
  51. 6.9.2 Pfizer Business Overview
  52. 6.9.3 Pfizer Bidirectional Immunomodulator Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Pfizer Bidirectional Immunomodulator Product Portfolio
  54. 6.9.5 Pfizer Recent Developments
  55. 6.10 Roche
  56. 6.10.1 Roche Company Information
  57. 6.10.2 Roche Business Overview
  58. 6.10.3 Roche Bidirectional Immunomodulator Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Roche Bidirectional Immunomodulator Product Portfolio
  60. 6.10.5 Roche Recent Developments
  61. 6.11 Merck
  62. 6.11.1 Merck Company Information
  63. 6.11.2 Merck Business Overview
  64. 6.11.3 Merck Bidirectional Immunomodulator Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Merck Bidirectional Immunomodulator Product Portfolio
  66. 6.11.5 Merck Recent Developments
  67. 6.12 Novartis
  68. 6.12.1 Novartis Company Information
  69. 6.12.2 Novartis Business Overview
  70. 6.12.3 Novartis Bidirectional Immunomodulator Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Novartis Bidirectional Immunomodulator Product Portfolio
  72. 6.12.5 Novartis Recent Developments
  73. 6.13 Takeda Pharmaceuticals
  74. 6.13.1 Takeda Pharmaceuticals Company Information
  75. 6.13.2 Takeda Pharmaceuticals Business Overview
  76. 6.13.3 Takeda Pharmaceuticals Bidirectional Immunomodulator Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Takeda Pharmaceuticals Bidirectional Immunomodulator Product Portfolio
  78. 6.13.5 Takeda Pharmaceuticals Recent Developments
  79. 6.14 Zhifei Biological
  80. 6.14.1 Zhifei Biological Company Information
  81. 6.14.2 Zhifei Biological Business Overview
  82. 6.14.3 Zhifei Biological Bidirectional Immunomodulator Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Zhifei Biological Bidirectional Immunomodulator Product Portfolio
  84. 6.14.5 Zhifei Biological Recent Developments
7 North America by Country
  1. 7.1 North America Bidirectional Immunomodulator Sales by Country
  2. 7.1.1 North America Bidirectional Immunomodulator Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Bidirectional Immunomodulator Sales by Country (2021-2026)
  4. 7.1.3 North America Bidirectional Immunomodulator Sales Forecast by Country (2027-2032)
  5. 7.2 North America Bidirectional Immunomodulator Market Size by Country
  6. 7.2.1 North America Bidirectional Immunomodulator Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Bidirectional Immunomodulator Market Size by Country (2021-2026)
  8. 7.2.3 North America Bidirectional Immunomodulator Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Bidirectional Immunomodulator Sales by Country
  2. 8.1.1 Europe Bidirectional Immunomodulator Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Bidirectional Immunomodulator Sales by Country (2021-2026)
  4. 8.1.3 Europe Bidirectional Immunomodulator Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Bidirectional Immunomodulator Market Size by Country
  6. 8.2.1 Europe Bidirectional Immunomodulator Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Bidirectional Immunomodulator Market Size by Country (2021-2026)
  8. 8.2.3 Europe Bidirectional Immunomodulator Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Bidirectional Immunomodulator Sales by Country
  2. 9.1.1 Asia-Pacific Bidirectional Immunomodulator Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Bidirectional Immunomodulator Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Bidirectional Immunomodulator Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Bidirectional Immunomodulator Market Size by Country
  6. 9.2.1 Asia-Pacific Bidirectional Immunomodulator Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Bidirectional Immunomodulator Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Bidirectional Immunomodulator Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Bidirectional Immunomodulator Sales by Country
  2. 10.1.1 South America Bidirectional Immunomodulator Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Bidirectional Immunomodulator Sales by Country (2021-2026)
  4. 10.1.3 South America Bidirectional Immunomodulator Sales Forecast by Country (2027-2032)
  5. 10.2 South America Bidirectional Immunomodulator Market Size by Country
  6. 10.2.1 South America Bidirectional Immunomodulator Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Bidirectional Immunomodulator Market Size by Country (2021-2026)
  8. 10.2.3 South America Bidirectional Immunomodulator Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Bidirectional Immunomodulator Sales by Country
  2. 11.1.1 Middle East and Africa Bidirectional Immunomodulator Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Bidirectional Immunomodulator Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Bidirectional Immunomodulator Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Bidirectional Immunomodulator Market Size by Country
  6. 11.2.1 Middle East and Africa Bidirectional Immunomodulator Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Bidirectional Immunomodulator Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Bidirectional Immunomodulator Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Bidirectional Immunomodulator Value Chain Analysis
  2. 12.1.1 Bidirectional Immunomodulator Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Bidirectional Immunomodulator Production Mode & Process
  7. 12.2 Bidirectional Immunomodulator Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Bidirectional Immunomodulator Distributors
  10. 12.2.3 Bidirectional Immunomodulator Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst